Reply
- PMID: 36057078
- DOI: 10.1002/hep.32718
Reply
References
-
- Jiang S‐T, Xu Y‐Y, Lu X. Letter to the editor: focus on MAFLD, even if patients have a history of excessive alcohol consumption. Hepatology. 2022. https://doi.org/10.1002/hep.32722 - DOI
-
- van Kleef LA, de Knegt RJ, Brouwer WP. Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality. Hepatology. 2022. https://doi.org/10.1002/hep.32642 - DOI
-
- Ikram MA, VanderWeele TJ. A proposed clinical and biological interpretation of mediated interaction. Eur J Epidemiol. 2015;30:1115–8.
-
- Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A. Metabolic dysfunction‐associated fatty liver disease is associated with increased all‐cause mortality in the United States. J Hepatol. 2021;75:1284–91.
-
- Younossi ZM, Paik JM, Al Shabeeb R, Younossi ZM, Paik JM, Younossi ZM, et al. Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease? Hepatology. 2022. https://doi.org/10.1002/hep.32499 - DOI
Grants and funding
LinkOut - more resources
Full Text Sources